Dynacirc News
GlaxoSmithKline Completes Acquisition of Reliant Pharmaceuticals - PR Newswire (press release)
They are DynaCirc CR(R) (isradipine) and InnoPran XL(R) (propanolol HCl), which treat high blood pressure, and Rythmol SR(R) (propafenone), which treats ...
GlaxoSmithKline Completes Reliant Buyout - Motley Fool
Reliant also makes high blood pressure drugs DynaCirc CR and InnoPran XL, and the abnormal heart rhythm treatment Rythmol SR. ...
GlaxoSmithKline buys Lovaza-maker Reliant for $1.65B - Bizjournals.com
Other Reliant products acquired by GlaxoSmithKline are DynaCirc and InnoPran, which treat high blood pressure, and Rythmol , which treats abnormal heart ...
glaxosmithkline to acquire Reliant Pharmaceuticals - News-Medical.net
... NJ, currently markets three other in-licensed cardiovascular products - high blood pressure treatments dynacirc CR(R) (isradipine) and innopran XL(R) ...
GSK buys Reliant for cardiovascular drugs - In-PharmaTechnologist.com
In addition to Lovaza, Reliant also markets three other in-licensed cardiovascular products - high blood pressure treatments dynacirc CR (isradipine) and ...
New Parkinson’s Treatment on the Horizon - Ivanhoe
Researchers from Northwestern University found isradipine (DynaCirc), a drug widely used to treat cardiac hypertension and stroke, can restore the worn out ...
Hypertension drug protects against Parkinson's - New Scientist (subscription)
Human trials of isradipine (or DynaCirc) – which is prescribed for hypertension and stroke – are now planned. Over time, Parkinson's patients lose a set of ...
Test drug seen as best hope in decades for tackling Parkinson's - China Daily
Surmeier's hunch was to try isradipine, a well-tolerated hypertension and stroke drug commercialised under the name of DynaCirc, which blocks the channels ...
Study shows hypertension drug protects against Parkinson's - Xinhua
The drug prescribed for hypertension and stroke is isradipine (or DynaCirc), which scientists believe blocks the same type of calcium channel. ...
Blood Pressure Drug May Curb Parkinson's - CBS News
A new study shows that the calcium-channel blocker DynaCirc may curb Parkinson's disease by making old brain cells act like younger versions of themselves. ...
Dynacirc RSS Feed